Nandrolone vs Primobolan: What to Choose and for Whom

Nandrolone and Primobolan (metenolone) are often contrasted as a «bulking» and a «quality» anabolic. The editorial team offers a different lens: to look at the clinical situations in which these substances were actually used, for whom they were indicated, and for whom their risks outweigh any expected benefit.

The clinical niche of nandrolone

Nandrolone decanoate is one of the few anabolic steroids that has retained registration as a medicine in a number of countries. Historically it was prescribed for anemia associated with chronic kidney disease, for some forms of osteoporosis, and also for cachexia against the background of severe chronic illnesses.

The most convincing clinical data concern patients on hemodialysis. In a randomized trial by Johansen and colleagues (1999), nandrolone decanoate increased lean body mass and improved certain measures of physical function compared with placebo. Similar results were obtained in patients with HIV-associated wasting.

However, with the advent of recombinant erythropoietin and other erythropoiesis-stimulating agents, the role of nandrolone in the treatment of anemia has significantly diminished. Today it is considered only in individual cases and in countries where it has remained available.

Importantly, even in these situations nandrolone is prescribed by a doctor who weighs the benefits and risks for the particular patient, monitors hematocrit, lipids, liver function and, in women, signs of virilization.

Why metenolone lost its clinical niche

Metenolone was used for approximately the same purposes — anemia due to bone marrow failure and wasting — but its evidence base was always more modest. There are almost no modern randomized trials with it.

With the development of hematology (erythropoiesis-stimulating agents, bone marrow transplantation, immunosuppressive therapy for aplastic anemia), the need for anabolic steroids for these conditions decreased. Metenolone gradually disappeared from the pharmaceutical markets of most countries.

Accordingly, the modern medical picture looks like this: nandrolone still has narrow indications in some jurisdictions, metenolone — practically none. This is the main difference from the standpoint of the question «for whom».

For men with testosterone deficiency, neither of the two substances is the agent of choice: in such a situation guidelines recommend testosterone preparations themselves.

The myth of the «joint steroid»

In the sports community there is a widespread belief that nandrolone «treats the joints» and is therefore suitable for people with injuries or joint pain. This claim is worth considering separately, since it often becomes an argument in favor of the choice.

Nandrolone has indeed been studied for its effect on collagen and bone tissue, and in some countries it was used for osteoporosis. Some animal studies point to an effect of anabolic steroids on collagen synthesis in tendons. However, there are no controlled studies that would show that nandrolone treats joint or ligament injuries in humans.

The subjective reduction in pain reported by users may have various explanations, in particular fluid retention and a general effect on well-being. At the same time, there is data that anabolic steroids change the mechanical properties of tendons, and cases of tendon ruptures in users have been described.

So a person with joint pain needs diagnosis by a traumatologist or rheumatologist and appropriate treatment, rather than a choice between nandrolone and metenolone.

Fertility and recovery of the hormonal axis

For men who plan to have children, this question often becomes key. Any androgen suppresses the production of LH and FSH and, accordingly, spermatogenesis. Nandrolone is distinguished by especially pronounced suppression due to its additional progestagenic activity.

A review by Rahnema and colleagues (2014) describes anabolic-steroid-induced hypogonadism as a common cause of severe testosterone decline in young men. Recovery can take from several months to considerably longer periods, and in some people hormonal function does not fully recover.

The duration of recovery depends on the duration of use, the number of substances, the person's age and the initial state of the hormonal system. The long ester of nandrolone decanoate also lengthens the period during which the substance continues to act after the last injection.

We also highlight buy cardarine biaxol.

Metenolone has no progestagenic activity, but it too suppresses the axis. So for a man planning children, the non-medical use of either of these substances carries a direct risk to fertility.

The practical conclusion: if the question of fertility is relevant, the optimal step is a consultation with an andrologist and a spermogram, rather than a search for a «less suppressive» steroid.

Women and athletes under doping control

For women both substances carry the risk of virilization. Nandrolone was in the past prescribed to postmenopausal women for osteoporosis, and even under medical conditions a deepening of the voice and hirsutism were observed. Metenolone, despite its reputation as a «women's» steroid, is also a full-fledged androgen.

The signs of virilization to watch for are as follows:

• a change in the timbre of the voice, hoarseness;
• growth of hair on the face and body in a male pattern;
• acne and increased oiliness of the skin;
• menstrual cycle disorders;
• enlargement of the clitoris.

Changes in the voice and the clitoris are often irreversible, even if use is stopped immediately after the first signs appear.

For athletes who undergo doping control, both substances are prohibited (section S1 of the WADA Prohibited List). Nandrolone has an especially long detection of metabolites, so the risk of a positive result persists long after use has stopped.

Editorial conclusions

Nandrolone has a narrow but real clinical history — anemia in chronic kidney disease, wasting, osteoporosis — although today it has largely been displaced by other agents. Metenolone has practically disappeared from medical practice.

For healthy people neither substance has any indications. The myth of «treating the joints» with nandrolone is not confirmed by clinical studies, and its pronounced suppression of the hormonal axis makes it especially risky for men who plan to have children.

Women and athletes under doping control should refrain from both substances.

We also recommend reading our materials on anabolic-steroid-induced hypogonadism, on the spermogram and male fertility, and on evidence-based methods of recovery after tendon injuries.

References

1. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999;281(14):1275–1281.
2. Rahnema CD, Lipshultz LI, Crosnoe LE, et al. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271–1279.
3. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
4. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521.
5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
6. World Anti-Doping Agency. The Prohibited List. International Standard. Montreal: WADA; 2025.